Compare Stocks

→ Here’s how to start a “Weekend Side Hustle” from your sofa (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DNA Ginkgo Bioworks	$0.86 +2.5%	$1.19	$0.81 ▼ $2.55	$1.86B	1.36	24.00 million shs	33.53 million shs
EIHDF 888	$0.97	$1.08	$0.87 ▼ $1.63	N/A	N/A	14,785 shs	N/A
GXYEF Galaxy Entertainment Group	$4.35	$5.24	$4.35 ▼ $7.44	N/A	N/A	10,026 shs	N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DNA Ginkgo Bioworks	-2.66%	-11.57%	-21.32%	-33.97%	-35.73%
EIHDF 888	0.00%	-4.36%	-7.35%	-7.35%	+2.40%
GXYEF Galaxy Entertainment Group	0.00%	-15.63%	-12.55%	-13.86%	-40.65%

The Hard Truth About Investing For Retirement (Ad)

Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.

Click To Access This Powerful Training Right Now!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DNA Ginkgo Bioworks	1.1273 of 5 stars	3.0	0.0	0.0	0.0	1.7	3.3	0.6
EIHDF 888	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GXYEF Galaxy Entertainment Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DNA Ginkgo Bioworks	2.00	Hold	$2.20	154.57% Upside
EIHDF 888	N/A	N/A	N/A	N/A
GXYEF Galaxy Entertainment Group	3.00	Buy	N/A	N/A

Current Analyst Ratings

Latest CWN, EIHDF, DNA, and GXYEF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/1/2024	DNA Ginkgo Bioworks	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$7.00 ➝ $3.00

(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DNA Ginkgo Bioworks	$251.46M	7.40	N/A	N/A	$0.55 per share	1.57
EIHDF 888	N/A	N/A	N/A	N/A	N/A	N/A
GXYEF Galaxy Entertainment Group	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DNA Ginkgo Bioworks	-$892.87M	-$0.47	N/A	N/A	N/A	-355.08%	-48.23%	-31.35%	5/8/2024 (Estimated)
EIHDF 888	N/A	$0.14	7.17	∞	N/A	N/A	N/A	N/A	N/A
GXYEF Galaxy Entertainment Group	N/A	$2.65	1.64	∞	N/A	N/A	N/A	N/A	N/A

Latest CWN, EIHDF, DNA, and GXYEF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	12/31/2023	DNA Ginkgo Bioworks	-$0.09	-$0.10	-$0.01	-$0.07	$40.37 million	$34.76 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DNA Ginkgo Bioworks	N/A	N/A	N/A	N/A	N/A
EIHDF 888	$0.14	14.39%	N/A	103.21%	N/A
GXYEF Galaxy Entertainment Group	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DNA Ginkgo Bioworks	N/A	6.11	6.11
EIHDF 888	N/A	N/A	N/A
GXYEF Galaxy Entertainment Group	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
DNA Ginkgo Bioworks	78.63%
EIHDF 888	14.77%
GXYEF Galaxy Entertainment Group	28.47%

Insider Ownership

Company	Insider Ownership
DNA Ginkgo Bioworks	15.05%
EIHDF 888	N/A
GXYEF Galaxy Entertainment Group	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DNA Ginkgo Bioworks	1,218	2.15 billion	1.83 billion	Optionable
EIHDF 888	11,000	N/A	N/A	Not Optionable
GXYEF Galaxy Entertainment Group	20,400	N/A	N/A	Not Optionable

CWN, EIHDF, DNA, and GXYEF Headlines

Source	Headline
	Morgan Stanley trims 2024 forecasts for Galaxy Ent ggrasia.com - April 17 at 12:11 AM
	Short Interest in Galaxy Entertainment Group Limited (OTCMKTS:GXYEF) Increases By 33.1% americanbankingnews.com - April 15 at 3:34 AM
	Galaxy Macau Celebrates A Trio Of Prestigious Accolades From Travel + Leisure China, The Ttg China Travel Awards, And The Vogue Hong Kong Beauty Awards msn.com - April 10 at 10:15 AM
	35 Guardians Of The Galaxy Quotes That Will Stick With Us Forever msn.com - April 8 at 2:34 AM
	Galaxy Arena Welcomes First Thai Superstar Solo Concert by Billkin on April 6 finance.yahoo.com - April 5 at 8:22 AM
	Commentary: After seven years of struggle, the unbeaten Galaxy are believing in themselves again msn.com - April 1 at 2:32 AM
	After seven years of struggle, the unbeaten Galaxy are believing in themselves again sports.yahoo.com - March 31 at 9:31 PM
	GALAXY MACAU UNVEILS THE SECOND SEASON OF GALAXY MACAU ARTISANS OF FLAVOR finance.yahoo.com - March 26 at 10:31 AM
	Guardians Of The Galaxy's Karen Gillan Reacts To Vol. 3's Star-Lord End-Credits Reveal, Shares Thoughts On Nebula's Future cinemablend.com - March 16 at 9:37 AM
	Guardians of the Galaxy star hints at possible DC dream casting dexerto.com - March 10 at 2:26 PM
	Buy Rating Affirmed for Galaxy Entertainment Group Amid Strong Fundamentals and Strategic Growth markets.businessinsider.com - February 29 at 11:49 PM
	Galaxy Ent mulls major revamp at StarWorld Hotel ggrasia.com - February 29 at 7:46 AM
	Analysts Offer Insights on Consumer Cyclical Companies: Galaxy Entertainment Group (OtherGXYEF), Cracker Barrel (CBRL) and Mercadolibre (MELI) markets.businessinsider.com - February 28 at 11:42 AM
	Galaxy Entertainment Group Reports Q4 & Annual 2023 Results markets.businessinsider.com - February 28 at 6:42 AM
	Galaxy Entertainment Group Reports Q4 & Annual 2023 Results finance.yahoo.com - February 28 at 6:42 AM
	Galaxy Entertainment Group Reports Q4 & Annual 2023 Results globenewswire.com - February 28 at 2:50 AM
	Buy Rating for Galaxy Entertainment Group Highlighting Strong Financials and Growth Prospects markets.businessinsider.com - February 16 at 2:26 AM
	Galaxy Entertainment: VIP-To-Mass Transition Is A Work-In-Progress seekingalpha.com - February 15 at 11:24 AM
	Samsung chief Jay Y. Lee found not guilty in 2015 merger case msn.com - February 5 at 8:46 AM
	40 Richest Countries in the World by Per Capita Net Worth finance.yahoo.com - February 1 at 6:05 PM
	Samsung, TfL to Promote 'Circle to Search' with Google Feature on New Galaxy S24 thefastmode.com - February 1 at 8:04 AM
	Everything Samsung announced at its Galaxy S24 event msn.com - January 18 at 3:10 PM
	Everything Samsung announced at its Galaxy S24 event today msn.com - January 17 at 3:32 PM
	Galaxy Macau floor revamp can aid GGR market share: GS ggrasia.com - January 12 at 7:51 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Ginkgo Bioworks

NYSE:DNA

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

888

OTCMKTS:EIHDF

888 Holdings plc, together with its subsidiaries, provides online betting and gaming products and solutions in the United Kingdom, Italy, Spain, and internationally. It operates through three segments Retail, UK Online, and International. The company engages in the operation of gaming machines; and sports betting, casino, poker, and other gaming products, as well as offers telephone betting services. The company owns and operates its business through William Hill, 888casino, 888poker, 888sport, Mr Green, SI Casino, and SI Sportsbook brands. 888 Holdings plc was founded in 1997 and is headquartered in Gibraltar, Gibraltar.

Galaxy Entertainment Group

OTCMKTS:GXYEF

Galaxy Entertainment Group Limited, an investment holding company, engages in the gaming and entertainment businesses in Macau, Hong Kong, and Mainland China. It operates through Gaming and Entertainment, and Construction Materials segments. The company operates casino games of chance or games of other forms; and provides hospitality and related services. It develops and operates Galaxy Macau, an integrated resort; Broadway Macau, a landmark entertainment and food street destination; StarWorld Macau, a five-star hotel located in the Macau Peninsula; and City Club casinos. The company also manufactures, sells, and distributes construction materials, including concrete pipes and piles, asphalt, ready-mixed concrete, cement, bricks, concrete products, aggregates, and slag; provides property investment, handling, quality assurance, project management, cross-border transportation, road marking, and security services; and imports, exports, trades in, and transports construction materials. In addition, it is involved in aircraft and vessel holding activities, truck leasing, and provision of road base and bituminous materials. The company was incorporated in 1987 and is based in Central, Hong Kong.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial